2370 — Medinet Co Share Price
0.000.00%
Last trade - 00:00- ¥12bn
- ¥7bn
- ¥662m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.12 | ||
| Price to Tang. Book | 2.16 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 16.97 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -23.3% | ||
| Return on Equity | -25.92% | ||
| Operating Margin | -195.33% | ||
Financial Summary
| Year End 30th Sep | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 1,059.02 | 783.03 | 683.03 | 633.67 | 661.54 | n/a | n/a | -7.9% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MEDINET Co., Ltd. is a Japan-based company mainly engaged in cell processing industry and cellular medical products business. It operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. It also provides comprehensive support services for immune cell therapy.
Directors
- Yoshiji Kimura CHM (64)
- Kunihiko Suzuki VCH (62)
- Daisuke Hara EXO (49)
- Yoshiaki Haruyama EXO (51)
- Hiromu Miyamoto OTH
- Shoji Ikeda DRC (67)
- Takashige Kondo DRC (43)
- Masami Ochiai DRC (44)
- Toshihisa Minamino IND (60)
- Takeshi Shinoda IND
- Tsukasa Takahashi IND
- Masaru Wada IND
- Koichiro Yoshino IND (69)
- Last Annual
- September 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- October 17th, 1995
- Public Since
- October 8th, 2003
- No. of Shareholders
- 55,137
- No. of Employees
- 98
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 256,190,242
- Address
- 9F, TRC Center Bldg., 6-1-1, Heiwajima, OTA-KU, 143-0006
- Web
- https://www.medinet-inc.co.jp/
- Phone
- +81 366311201
- Auditors
- Fugen Audit Corporation
Upcoming Events for 2370
Dividend For 2370.T - 0.0000 JPY
Similar to 2370
3-D Matrix
Tokyo Stock Exchange
AnGes
Tokyo Stock Exchange
BrightPath Biotherapeutics Co
Tokyo Stock Exchange
Carna Biosciences
Tokyo Stock Exchange
Chiome Bioscience
Tokyo Stock Exchange
FAQ
What is the Medinet Co share price?
As of Today at 19:14 UTC, shares in Medinet Co are trading at ¥48. This share price information is delayed by 15 minutes.
How has the Medinet Co share price performed this year?
Shares in Medinet Co last closed at ¥48 and the price had moved by -29.41% over the past 365 days. In terms of relative price strength the Medinet Co share price has underperformed the Nikkei 225 Index by -49.61% over the past year.
What are the analyst and broker recommendations for Medinet Co?
There is no consensus recommendation for this security.
What is the Medinet Co dividend yield?
Medinet Co does not currently pay a dividend.
Does Medinet Co pay a dividend?
Medinet Co does not currently pay a dividend.
When does Medinet Co next pay dividends?
Medinet Co does not currently pay a dividend.
How do I buy Medinet Co shares?
To buy shares in Medinet Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Medinet Co?
As of the previous close price of ¥48, shares in Medinet Co had a market capitalisation of ¥12bn.
Where are Medinet Co shares listed?
Here are the trading details for Medinet Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 2370
What kind of share is Medinet Co?
Based on an overall assessment of its quality, value and momentum Medinet Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Medinet Co share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Medinet Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medinet Co. Over the past six months, its share price has underperformed the Nikkei 225 Index by -16.24%.
As of the last closing price of ¥48, shares in Medinet Co were trading -5.01% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Medinet Co PE Ratio?
The Medinet Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥48.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Medinet Co?
Medinet Co's management team is headed by:
- Yoshiji Kimura - CHM
- Kunihiko Suzuki - VCH
- Daisuke Hara - EXO
- Yoshiaki Haruyama - EXO
- Hiromu Miyamoto - OTH
- Shoji Ikeda - DRC
- Takashige Kondo - DRC
- Masami Ochiai - DRC
- Toshihisa Minamino - IND
- Takeshi Shinoda - IND
- Tsukasa Takahashi - IND
- Masaru Wada - IND
- Koichiro Yoshino - IND